Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
24.1M
-
Shares change
-
+10.1M
-
Total reported value, excl. options
-
$1.44B
-
Value change
-
+$617M
-
Put/Call ratio
-
0.68
-
Number of buys
-
151
-
Number of sells
-
-56
-
Price
-
$59.91
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q3 2018
230 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q3 2018.
Medpace Holdings, Inc. - Common Stock (MEDP) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.1M shares
of 30.9M outstanding shares and own 78.01% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (2.9M shares), BlackRock Inc. (2.28M shares), ACADIAN ASSET MANAGEMENT LLC (1.46M shares), Laurion Capital Management LP (1.11M shares), DEUTSCHE BANK AG\ (810K shares), RENAISSANCE TECHNOLOGIES LLC (785K shares), AMERIPRISE FINANCIAL INC (721K shares), FULLER & THALER ASSET MANAGEMENT, INC. (622K shares), D. E. Shaw & Co., Inc. (541K shares), and STATE STREET CORP (510K shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.